The maker of weight-loss jabs Wegovy and Ozempic, Danish pharmaceutical giant Novo Nordisk, has reported a sharp rise in profits on the back of surging demand for the drugs. Net profits were 39.2bn kroner (£4.5bn) for the period from January to June, rising 43% from 27.5bn kroner a year earlier.

"I had already heard about Ozempic, and then I started seeing other people taking it, like celebrities, who suddenly were slimming down very quickly," she said. While officially approved for type 2 diabetes,

WASHINGTON—Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called “wonder drugs” described as revolutionary in the fight against obesity.